Glucosamine & Chondroitin with Hyaluronic Acid
Glucosamine & Chondroitin with Hyaluronic Acid, NPN 80096570: natural health product licensed in Canada. Medicinal ingredients: Sulfate de chondroïtine.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sulfate de chondroïtine Source : Bos taurus - cartilage | 400 mg | Not calculated |
| Sulfate de chondroïtine Source : Chondroïtin sulfate de sodium | 400 mg | Not calculated |
Non-medicinal ingredients
Eau purifiée, Gélatine, Stéarate de magnésium, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3 Capsule | 1 Tous les jours |
Uses authorised in Canada
Helps to protect against the deterioration of cartilage. A factor in maintaining healthy cartilage and/or health. Helps to relieve (joint) pain associated with osteoarthritis (of the knee).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a physician prior to use if you are pregnant or breastfeeding. Consult a physician if symptoms worsen. Keep out of reach of children.
Product record
- Licence holder
- WN Pharmaceuticals Ltd
- NPN or DIN-HM
- 80096570
- Status
- Active licence
- Licence date
- 9 January 2020
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
Source
Official Health Canada record, licence 80096570
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Glucosamine & Chondroitin with Hyaluronic Acid (WN Pharmaceuticals Ltd): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80096570-glucosamine-chondroitin-with-hyaluronic-acid, updated 9 January 2020.